易方达中证万得生物科技指数(LOF)C(010572)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-47,262,665.67 |
112,440,065.09 |
75,041,370.83 |
-187,240,579.12 |
| 利息合计 |
36,637.82 |
150,629.07 |
74,082.86 |
1,324,269.23 |
| 其中：存款利息收入 |
36,637.82 |
150,629.07 |
74,082.86 |
134,911.66 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-7,842,616.22 |
-101,449,675.50 |
-39,543,469.16 |
-79,024,209.36 |
| 其中：股票投资收益 |
-13,336,379.58 |
-111,559,633.19 |
-46,281,196.17 |
-89,266,010.25 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
131,906.85 |
72,147.95 |
- |
381,514.73 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
5,361,856.51 |
10,037,809.74 |
6,737,727.01 |
9,860,286.16 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-39,684,656.80 |
213,158,718.40 |
114,340,779.14 |
-109,866,693.10 |
| 其他收入 |
227,969.53 |
580,393.12 |
169,977.99 |
326,054.11 |
| 费用 |
2,374,046.15 |
5,456,431.38 |
2,464,774.25 |
5,011,337.28 |
| 管理人报酬 |
1,733,155.91 |
4,066,058.26 |
1,829,656.06 |
3,642,845.48 |
| 基金托管费 |
346,631.18 |
813,211.68 |
365,931.19 |
728,569.07 |
| 销售服务费 |
191,068.49 |
354,260.66 |
143,818.80 |
244,776.15 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
9,193.55 |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
9,193.55 |
- |
- |
- |
| 其他费用 |
93,997.02 |
222,900.78 |
125,368.20 |
390,864.54 |
| 利润总额 |
-49,636,711.82 |
106,983,633.71 |
72,576,596.58 |
-192,251,916.40 |
微信公众号
证券之星APP
基本资料
